胰岛素不错，可惜缺乏证据支持。 - Suppr

Suppr

超能文献

Nice insulins, pity about the evidence.

作者信息

Holleman F, Gale E A M

机构信息

Department of Internal Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands.

Diabetes and Metabolism, Medical School Unit, Southmead Hospital, Bristol, BS10 5NB, UK.

出版信息

Diabetologia. 2007 Sep;50(9):1783-1790. doi: 10.1007/s00125-007-0763-4.

DOI:10.1007/s00125-007-0763-4

PMID:17634918

Abstract

摘要

相似文献

Nice insulins, pity about the evidence.

Diabetologia. 2007 Sep;50(9):1783-1790. doi: 10.1007/s00125-007-0763-4.

Modern insulins--comment on facts and assumptions in a recent editorial.

Diabetologia. 2008 Apr;51(4):689-91. doi: 10.1007/s00125-007-0922-7. Epub 2008 Jan 22.

Insulin detemir: A historical perspective on a modern basal insulin analogue.

Prim Care Diabetes. 2010 Apr;4 Suppl 1:S31-42. doi: 10.1016/S1751-9918(10)60007-1.

From rabbits to the League of Nations: Early standardization of the insulin unit.

Pharos Alpha Omega Alpha Honor Med Soc. 2011 Winter;74(1):28-33.

Ideas, ideals, and innovation in the history of diabetes.

Arch Pediatr Adolesc Med. 2011 Mar;165(3):195-6. doi: 10.1001/archpediatrics.2011.7.

Challenges of optimizing insulin therapy for patients with type 2 diabetes mellitus.

J Diabetes Investig. 2021 Sep;12(9):1523-1525. doi: 10.1111/jdi.13609. Epub 2021 Jul 19.

[Medical treatment of type 2 diabetes. French Agency for the Health Safety of Health Products].

Diabetes Metab. 1999 Dec;25(6):533-50.

Post-marketing studies of new insulins: sales or science?

BMJ. 2012 Jun 12;344:e3974. doi: 10.1136/bmj.e3974.

Quality Control of Insulins and Biosimilar Insulins: What Do We Know?

J Diabetes Sci Technol. 2016 Jun 28;10(4):811-5. doi: 10.1177/1932296816638923. Print 2016 Jul.

[Type 2 diabetes: new insulins and new therapeutic strategies].

Diabetes Metab. 2004 Nov;30(5):478-80.

引用本文的文献

Design and Evaluation of Pegylated Large 3D Pore Ferrisilicate as a Potential Insulin Protein Therapy to Treat Diabetic Mellitus.

Pharmaceutics. 2023 Feb 9;15(2):593. doi: 10.3390/pharmaceutics15020593.

A Comprehensive Review of the Evolution of Insulin Development and Its Delivery Method.

Pharmaceutics. 2022 Jul 4;14(7):1406. doi: 10.3390/pharmaceutics14071406.

The insulin market reaches 100.

Diabetologia. 2022 Jun;65(6):931-935. doi: 10.1007/s00125-022-05680-y. Epub 2022 Mar 11.

Short-acting insulin analogues versus regular human insulin for adult, non-pregnant persons with type 2 diabetes mellitus.

Cochrane Database Syst Rev. 2018 Dec 17;12(12):CD013228. doi: 10.1002/14651858.CD013228.

Circadian clocks and insulin resistance.

Nat Rev Endocrinol. 2019 Feb;15(2):75-89. doi: 10.1038/s41574-018-0122-1.

Short-acting insulin analogues versus regular human insulin for adults with type 1 diabetes mellitus.

Cochrane Database Syst Rev. 2016 Jun 30;2016(6):CD012161. doi: 10.1002/14651858.CD012161.

Biphasic insulin Aspart 30 vs. NPH plus regular human insulin in type 2 diabetes patients; a cost-effectiveness study.

BMC Endocr Disord. 2016 Jun 9;16(1):35. doi: 10.1186/s12902-016-0116-8.

Evidence-informed clinical practice recommendations for treatment of type 1 diabetes complicated by problematic hypoglycemia.

Diabetes Care. 2015 Jun;38(6):1016-29. doi: 10.2337/dc15-0090.

Modern insulins, old paradigms and pragmatism: choosing wisely when deciding how to treat type 1 diabetes.

Diabetol Metab Syndr. 2015 Apr 22;7:35. doi: 10.1186/s13098-015-0033-4. eCollection 2015.

Evaluation of the incremental cost to the National Health Service of prescribing analogue insulin.

BMJ Open. 2011 Jan 1;1(2):e000258. doi: 10.1136/bmjopen-2011-000258.

本文引用的文献

Recrystallized insulin for diabetic patients with insulin allergy.

Arch Intern Med (Chic). 1949 Apr;83(4):363-71. doi: 10.1001/archinte.1949.00220330003001.

Comparison of once-daily insulin detemir with NPH insulin added to a regimen of oral antidiabetic drugs in poorly controlled type 2 diabetes.

Clin Ther. 2006 Oct;28(10):1569-81. doi: 10.1016/j.clinthera.2006.10.020.

Systematic evaluation of the quality of randomized controlled trials in diabetes.

Diabetes Care. 2006 Aug;29(8):1833-8. doi: 10.2337/dc06-0077.

Management of hyperglycaemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes.

Diabetologia. 2006 Aug;49(8):1711-21. doi: 10.1007/s00125-006-0316-2.

A 26-week, randomized, parallel, treat-to-target trial comparing insulin detemir with NPH insulin as add-on therapy to oral glucose-lowering drugs in insulin-naive people with type 2 diabetes.

Diabetes Care. 2006 Jun;29(6):1269-74. doi: 10.2337/dc05-1365.

To: Scholtz HE, Pretorius SG, Wessels DH, Becker RHA (2005) Pharmacokinetic and glucodynamic variability: assessment of insulin glargine, NPH insulin and insulin ultralente in healthy volunteers using a euglycaemic clamp technique. Diabetologia 48:1988-1995.

Diabetologia. 2006 May;49(5):1125-6. doi: 10.1007/s00125-006-0166-y. Epub 2006 Mar 7.

Improved glycaemic control with insulin glargine plus insulin lispro: a multicentre, randomized, cross-over trial in people with Type 1 diabetes.

Diabet Med. 2006 Mar;23(3):285-92. doi: 10.1111/j.1464-5491.2005.01781.x.

The market in diabetes.

Diabetologia. 2006 Feb;49(2):247-52. doi: 10.1007/s00125-005-0108-0.

Initiating insulin therapy in type 2 Diabetes: a comparison of biphasic and basal insulin analogs.

Diabetes Care. 2005 Feb;28(2):260-5. doi: 10.2337/diacare.28.2.260.

'Human' insulin versus animal insulin in people with diabetes mellitus.

Cochrane Database Syst Rev. 2005 Jan 25;2005(1):CD003816. doi: 10.1002/14651858.CD003816.pub2.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验